Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania

Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania

Abstract Background The elimination of Plasmodium vivax malaria requires 8-aminoquinolines, which are contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency due to the risk of acute haemolytic anaemia. Several point-of-care devices have been developed to detect G6PD def...

Full description

Bibliographic Details
Main Authors: Oum Kelthoum Mamadou Djigo, Yacoub Ould Khalef, Mohamed Salem Ould Ahmedou Salem, Nicolas Gomez, Leonardo Basco, Sébastien Briolant, Ali Ould Mohamed Salem Boukhary
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Infectious Diseases of Poverty
Subjects:
Glucose-6-phosphate dehydrogenase
Malaria
Plasmodium vivax
Primaquine
Tafenoquine
Online Access:https://doi.org/10.1186/s40249-021-00889-2

Internet

https://doi.org/10.1186/s40249-021-00889-2

Similar Items